Development and validation of an EUS-based nomogram for prediction of the malignant potential in gastrointestinal stromal tumors

References

• Poveda A, García Del Muro X, López-Guerrero JA, et al. GEIS guidelines for gastrointestinal sarcomas (GIST). Cancer Treat Rev. 2017;55:107–119.
   PubMed Web of Science ®Google Scholar
• Trinh VQ, Dashti NK, Cates JMM. A proposed risk assessment score for gastrointestinal stromal tumors based on evaluation of 19,030 cases from the national cancer database. J Gastroenterol. 2021;56(11):964–975.
   PubMed Web of Science ®Google Scholar
• von Mehren M, Kane JM, Bui MM, et al. NCCN guidelines insights: soft tissue sarcoma, version 1.2021. J Natl Compr Canc Netw. 2020;18(12):1604–1612.
   PubMedGoogle Scholar
• Steeghs EMP, Gelderblom H, Ho VKY, et al. Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice. Gastric Cancer. 2021;24(5):990–1002.
   PubMed Web of Science ®Google Scholar
• Rutkowski P, Wozniak A, Dębiec-Rychter M, et al. Clinical utility of the new American joint committee on cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection. Cancer. 2011;117(21):4916–4924.
   PubMed Web of Science ®Google Scholar
• Lartigue L, Neuville A, Lagarde P, et al. Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy. Eur J Cancer. 2015;51(1):75–83.
   PubMed Web of Science ®Google Scholar
• Kitamura Y. Gastrointestinal stromal tumors: past, present, and future. J Gastroenterol. 2008;43(7):499–508.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhong G, Zhou W, et al. Initial application of transanal endoscopic microsurgery for high-risk lower rectal gastrointestinal stromal tumor after imatinib mesylate neoadjuvant chemotherapy: a case report. Medicine. 2017;96(29):e7538.
   PubMed Web of Science ®Google Scholar
• Xu SJ, Zhang SY, Dong LY, et al. Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival. BMC Cancer. 2021;21(1):1170.
   PubMed Web of Science ®Google Scholar
• Joensuu H, Hohenberger P, Corless CL. Gastrointestinal stromal tumour. Lancet. 2013;382(9896):973–983.
   PubMed Web of Science ®Google Scholar
• Joensuu H, Vehtari A, Riihimäki J, et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 2012;13(3):265–274.
   PubMed Web of Science ®Google Scholar
• Yang X, Wang H, Dong Q, et al. An artificial intelligence system for distinguishing between gastrointestinal stromal tumors and leiomyomas using endoscopic ultrasonography. Endoscopy. 2022;54(3):251–261.
   PubMedGoogle Scholar
• Lim KT, Tan KY. Current research and treatment for gastrointestinal stromal tumors. World J Gastroenterol. 2017;23(27):4856–4866.
   PubMed Web of Science ®Google Scholar
• Nishida T, Goto O, Raut CP, et al. Diagnostic and treatment strategy for small gastrointestinal stromal tumors. Cancer. 2016;122(20):3110–3118.
   PubMed Web of Science ®Google Scholar
• Polkowski M, Jenssen C, Kaye P, et al. Technical aspects of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) technical Guideline – March 2017. Endoscopy. 2017;49(10):989–1006.
   PubMed Web of Science ®Google Scholar
• Kanno A, Yasuda I, Irisawa A, et al. Adverse events of endoscopic ultrasound-guided fine-needle aspiration for histologic diagnosis in Japanese tertiary centers: multicenter retrospective study. Dig Endosc. 2021;33(7):1146–1157.
   PubMed Web of Science ®Google Scholar
• Fujii LL, Levy MJ. Basic techniques in endoscopic ultrasound-guided fine needle aspiration for solid lesions: adverse events and avoiding them. Endosc Ultrasound. 2014;3(1):35–45.
   PubMed Web of Science ®Google Scholar
• Nishida T, Sakai Y, Takagi M, et al. Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world. Gastric Cancer. 2020;23(1):118–125.
   PubMed Web of Science ®Google Scholar
• Ren C, Wang S, Zhang S. Development and validation of a nomogram based on CT images and 3D texture analysis for preoperative prediction of the malignant potential in gastrointestinal stromal tumors. Cancer Imaging. 2020;20(1):5.
   PubMed Web of Science ®Google Scholar
• Wang K, Xu J, Li S, et al. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer among patients with papillary thyroid microcarcinoma. Cancer Med. 2019;8(16):6977–6985.
   PubMed Web of Science ®Google Scholar
• Jiaxin L, Peiyun Z, Zheng T, et al. Comparison of prognostic prediction models for rectal gastrointestinal stromal tumor. Aging. 2020;12(12):11416–11430.
   PubMedGoogle Scholar
• Liu YY, Zhao RF, Liu C, et al. Development and validation of nomograms to predict overall survival outcomes in serous ovarian cancer patients with satisfactory cytoreductive surgery and chemotherapy. Int J Gen Med. 2022;15:123–131.
   PubMed Web of Science ®Google Scholar
• Grobman WA, Stamilio DM. Methods of clinical prediction. Am J Obstet Gynecol. 2006;194(3):888–894.
   PubMed Web of Science ®Google Scholar
• Wong NA. Gastrointestinal stromal tumours–an update for histopathologists. Histopathology. 2011;59(5):807–821.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Feng M, Wang M, et al. CT Radiomics for the preoperative prediction of Ki67 index in gastrointestinal stromal tumors: a multi-center study. Front Oncol. 2021;11:689136.
   PubMedGoogle Scholar
• Iannicelli E, Carbonetti F, Federici GF, et al. Evaluation of the relationships between computed tomography features, pathological findings, and prognostic risk assessment in gastrointestinal stromal tumors. J Comput Assist Tomogr. 2017;41(2):271–278.
   PubMed Web of Science ®Google Scholar
• Cao L, Zheng K, Wang H, et al. Laparoscopic and endoscopic cooperative dissection for small gastric gastrointestinal stromal tumor without causing injury to the mucosa. Gastroenterol Res Pract. 2019;2019:1–7.
   Web of Science ®Google Scholar
• Song Y, Li J, Wang H, et al. Radiomics nomogram based on contrast-enhanced CT to predict the malignant potential of gastrointestinal stromal tumor: a two-center study. Acad Radiol. 2022;29(6):806–816.
   PubMed Web of Science ®Google Scholar
• Cho IR, Park JC, Roh YH, et al. Noninvasive prediction model for diagnosing gastrointestinal stromal tumors using contrast-enhanced harmonic endoscopic ultrasound. Dig Liver Dis. 2019;51(7):985–992.
   PubMedGoogle Scholar
• Zhao Q, Li Y, Yang P, et al. Evaluation for therapeutic measures to small gastric stromal tumor: a retrospective study of 90 cases. Curr Probl Cancer. 2018;42(1):107–114.
   PubMed Web of Science ®Google Scholar
• Nishida T, Yoshinaga S, Takahashi T, et al. Recent Progress and challenges in the diagnosis and treatment of gastrointestinal stromal tumors. Cancers. 2021;13(13):3158.
   PubMed Web of Science ®Google Scholar
• Yang Z, Gao Y, Fan X, et al. A multivariate prediction model for high malignancy potential gastric GI stromal tumors before endoscopic resection. Gastrointest Endosc. 2020;91(4):813–822.
   PubMed Web of Science ®Google Scholar
• Bai C, Liu X, Qiu C, et al. FoxM1 is regulated by both HIF-1α and HIF-2α and contributes to gastrointestinal stromal tumor progression. Gastric Cancer. 2019;22(1):91–103.
   PubMed Web of Science ®Google Scholar
• Wei SC, Xu L, Li WH, et al. Risk stratification in GIST: shape quantification with CT is a predictive factor. Eur Radiol. 2020;30(4):1856–1865.
   PubMed Web of Science ®Google Scholar
• Chen TH, Hsu CM, Chu YY, et al. Association of endoscopic ultrasonographic parameters and gastrointestinal stromal tumors (GISTs): can endoscopic ultrasonography be used to screen gastric GISTs for potential malignancy? Scand J Gastroenterol. 2016;51(3):374–377.
   PubMed Web of Science ®Google Scholar